Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference
Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, has announced its participation in the upcoming Canaccord Genuity Global Growth Conference. Rob Claypoole, the company's President and CEO, will engage in a fireside chat on Tuesday, August 12, 2025, at 2:00 p.m. ET.
The presentation will include a question-and-answer session and will be accessible via live webcast through the "Investors" section of Bioventus's website. A replay of the event will be made available on the company's website following the presentation.
Bioventus (Nasdaq: BVS), leader mondiale nelle innovazioni per la guarigione attiva, ha annunciato la sua partecipazione alla prossima Canaccord Genuity Global Growth Conference. Rob Claypoole, Presidente e CEO dell'azienda, parteciperà a una conversazione informale il martedì 12 agosto 2025, alle 14:00 ET.
La presentazione includerà una sessione di domande e risposte e sarà accessibile tramite webcast in diretta nella sezione "Investitori" del sito web di Bioventus. Una registrazione dell'evento sarà disponibile sul sito dell'azienda dopo la presentazione.
Bioventus (Nasdaq: BVS), líder global en innovaciones para la curación activa, ha anunciado su participación en la próxima Conferencia de Crecimiento Global de Canaccord Genuity. Rob Claypoole, Presidente y CEO de la compañía, participará en una charla informal el martes 12 de agosto de 2025 a las 2:00 p.m. ET.
La presentación incluirá una sesión de preguntas y respuestas y será accesible mediante webcast en vivo a través de la sección "Inversores" del sitio web de Bioventus. Una repetición del evento estará disponible en el sitio web de la compañía después de la presentación.
Bioventus (나스닥: BVS)는 활동적인 치유 혁신 분야의 글로벌 리더로서 다가오는 Canaccord Genuity 글로벌 성장 컨퍼런스에 참여할 것임을 발표했습니다. 회사의 사장 겸 CEO인 Rob Claypoole가 2025년 8월 12일 화요일 오후 2시 ET에 파이어사이드 채팅에 참여할 예정입니다.
발표 후 질의응답 시간이 포함되며, Bioventus 웹사이트의 "투자자" 섹션을 통해 라이브 웹캐스트로 시청할 수 있습니다. 발표 후에는 회사 웹사이트에서 다시보기 영상도 제공될 예정입니다.
Bioventus (Nasdaq : BVS), leader mondial des innovations pour la guérison active, a annoncé sa participation à la prochaine Canaccord Genuity Global Growth Conference. Rob Claypoole, président et CEO de l'entreprise, participera à une discussion informelle le mardi 12 août 2025 à 14h00 ET.
La présentation comprendra une session de questions-réponses et sera accessible via un webcast en direct dans la section « Investisseurs » du site web de Bioventus. Un replay de l'événement sera disponible sur le site de l'entreprise après la présentation.
Bioventus (Nasdaq: BVS), ein weltweit führendes Unternehmen für Innovationen im Bereich der aktiven Heilung, hat seine Teilnahme an der bevorstehenden Canaccord Genuity Global Growth Conference angekündigt. Rob Claypoole, Präsident und CEO des Unternehmens, wird am Dienstag, den 12. August 2025, um 14:00 Uhr ET an einem Fireside-Chat teilnehmen.
Die Präsentation umfasst eine Frage-und-Antwort-Runde und ist über einen Live-Webcast im Bereich "Investoren" auf der Website von Bioventus zugänglich. Eine Aufzeichnung der Veranstaltung wird nach der Präsentation auf der Unternehmenswebsite verfügbar sein.
- None.
- None.
DURHAM, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief Executive Officer, will participate in a fireside chat at the Canaccord Genuity Global Growth Conference on Tuesday, August 12, 2025, at 2:00 p.m. ET.
A live webcast of the presentation, followed by a question-and-answer session will be available on the “Investors” section of the Company’s website at www.bioventus.com and will be available for replay on that site following the event.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com, and follow the Company on LinkedIn and X. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Contact:
Dave Crawford
919-474-6787
dave.crawford@bioventus.com
FAQ
When is Bioventus (BVS) presenting at the Canaccord Genuity Conference?
Who will represent Bioventus at the Canaccord Genuity Conference?
How can investors access Bioventus's presentation at the Canaccord Conference?
Will there be a replay available of Bioventus's Canaccord Conference presentation?
